Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals

Annals of Neurology

Volumn 42, Issue 1, 1997, Pages 18-27

  Hermans, Guy ^a,c   Stinissen, Piet ^a   Hauben, Lysiane ^a   Van Den Berg Loonen, Ella ^b   Raus, Jef ^a   Zhang, Jingwu ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Universitaire Campus   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN BASIC PROTEIN; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; CELL LINE; CLONE CELLS; CYTOKINES; ENTEROTOXINS; FEMALE; HAPLOTYPES; HLA ANTIGENS; HUMANS; KINETICS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0030844435     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420106     Document Type: Article

References (37)

1. Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981;11: 195-204
2. Ando DG, Clayton J, Kono D, et al. Encephalitogenic T-cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 subtype. Cell Immunol 1989;124:132-143
3. Powell MB, Mitchell D, Lederman J, et al. Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalogenicity. Int Immunol 1990;2:539-544
4. Ruddle NH, Bergman CM, McGrath KM, et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990;172: 1193-1200
5. Sommer N, Löschmann PA, Northoff GH, et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med 1995;1:244-248
6. Racke MK, Burnett D, Pak SH, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995;154:450-458
7. French-Contant C. Pathogenesis of multiple sclerosis. Lancet 1994;343:271-275
8. Selmaj K, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23: 339-346
9. IFNβ multiple sclerosis study group and the University of British Columbia MS/MRI Analysis Group. Interferon β-1B in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285
10. Chen Y, Kuchroo VK, Inobe J-I, et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240
11. Zhang J. Multiple sclerosis: perspectives on autoimmune pathology and prospects for therapy. In: Appel SH, ed. Current neurology, vol 15. St Louis: Mosby-Year Book, 1995:115-155
12. Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 1997;17: 33-75
13. Zhang J, Markovic-Plese S, Lacet B, et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179:973-984
14. Chou YK, Bourdette DN, Offner H, et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1991;38:105-113
15. Wucherpfennig K, Zhang J, Witek K, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994;152:5581-5592
16. Vandevyver C, Mertens N, Van den Elsen P, et al. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995;25:958-968
17. Hafler D, Benjamin D, Burks J, et al. Myelin basic protein and proteolipid protein reactivity of brain and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J Immunol 1987;139:68-72
18. Meinl E, Weber F, Drexler K, et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 1993;92: 2633-2643
19. Salvetti M, Ristori G, D'Amato M, et al. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 1993;23:1232-1239
20. Fabry Z, Raine CS, Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994;15:218-224
21. Wong D, Korovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 1992;39:11-22
22. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173
23. + T cell subset with an unrestricted cytokine profile. J Immunol 1989;143:518-525
24. + T cell clones. J Immunol 1988;3:849-855
25. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein of several mammalian species. Prep Biochem 1972;2:139-144
26. Zhang J, Lambrechts J, Heyligen H, et al. Human B cell lines secreting IgM antibody specific for myelin basic protein. J Neuroimmunol 1989;23:249-256
27. Radoux D, De Groote D. The total cytokine concept: the influence of soluble receptors in the cytokine measurement. In: Bergmann L, Mitrou PS, eds. Contributions in oncology, vol 46. Basel: Karger, 1994:251-259
28. Elston RC, Johnson WD. Essentials of biostatistics. Philadelphia: FA Davis, 1987:140
29. Drake CG, Kotzin BL. Superantigens: biology, immunology, and potential role in disease. J Clin Invest 1992;12:149-162
30. Zhang J, Vandevyver C, Stinissen P, et al. Activation and clonal expansion of human myelin basic protein-reactive T cells by bacterial superantigens. J Autoimm 1995;8:615-632
31. Olsson T, Sun J, Hillert J, et al. Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol 1992;22:1083-1087
32. Navikas V, He B, Link J, et al. Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996;119:213-223
33. Braun N, Michel U, Ernst BP, et al. Gene polymorphism at position -308 or the tumor necrosis factor-α in multiple sclerosis and its influence on the regulation of TNFα production. Neurosci Lett 1996;215:75-78
34. Sandberg-Wollheim M, Ciusani E, Salmaggi A, et al. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Multiple Sclerosis 1995;1: 181-185
35. He B, Navikas V, Lundahl J, et al. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 1995;63:143-147
36. Vandevyver C, Raus P, Stinissen P, et al. Polymorphism of the tumour necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet 1994;21:377-382
37. + T cells. Ann Neurol 1995;38: 723-730